- Home
- ICCM vs IPSC Comparison
ICCM vs IPSC Comparison
Compare ICCM & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- IPSC
- Stock Information
- Founded
- ICCM 2006
- IPSC 2019
- Country
- ICCM Israel
- IPSC United States
- Employees
- ICCM N/A
- IPSC N/A
- Industry
- ICCM
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- ICCM
- IPSC Health Care
- Exchange
- ICCM Nasdaq
- IPSC Nasdaq
- Market Cap
- ICCM 55.8M
- IPSC 49.6M
- IPO Year
- ICCM N/A
- IPSC 2021
- Fundamental
- Price
- ICCM $0.99
- IPSC $0.54
- Analyst Decision
- ICCM Strong Buy
- IPSC Strong Buy
- Analyst Count
- ICCM 1
- IPSC 5
- Target Price
- ICCM $2.50
- IPSC $3.33
- AVG Volume (30 Days)
- ICCM 278.9K
- IPSC 1.2M
- Earning Date
- ICCM 08-19-2025
- IPSC 08-07-2025
- Dividend Yield
- ICCM N/A
- IPSC N/A
- EPS Growth
- ICCM N/A
- IPSC N/A
- EPS
- ICCM N/A
- IPSC N/A
- Revenue
- ICCM $3,273,000.00
- IPSC $114,898,000.00
- Revenue This Year
- ICCM $83.41
- IPSC $1,064.82
- Revenue Next Year
- ICCM $185.02
- IPSC N/A
- P/E Ratio
- ICCM N/A
- IPSC N/A
- Revenue Growth
- ICCM 0.34
- IPSC 8286.72
- 52 Week Low
- ICCM $0.48
- IPSC $0.34
- 52 Week High
- ICCM $1.66
- IPSC $3.29
- Technical
- Relative Strength Index (RSI)
- ICCM 46.56
- IPSC 48.22
- Support Level
- ICCM $0.81
- IPSC $0.55
- Resistance Level
- ICCM $1.03
- IPSC $0.60
- Average True Range (ATR)
- ICCM 0.06
- IPSC 0.04
- MACD
- ICCM 0.01
- IPSC -0.00
- Stochastic Oscillator
- ICCM 75.00
- IPSC 15.96
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.